Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-08-07 17:04:18
Reporting Period:
Accepted Time:
2020-08-07 17:04:18
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1235010 Momenta Pharmaceuticals Inc MNTA Biological Products, (No Disgnostic Substances) (2836) 043561634
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379970 C Steven Gilman C/o Momenta Pharmaceuticals, Inc
301 Binney Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-05 13,000 $10.63 20,796 No 4 M Direct
Common Stock Disposition 2020-08-05 13,000 $32.75 7,796 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-08-05 13,000 $0.00 13,000 $10.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-06-22 2026-06-22 No 4 M Direct
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020
  2. This transaction was executed in multiple trades at prices ranging from $32.27 to $32.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.